Andorra vs Bermuda: The number of people with susceptibility test result for rifampicin
Andorra
2
in 2021
Bermuda
2
in 2021
Andorra rank
143rd
Bermuda rank
143rd
The number of people with susceptibility test result for rifampicin over time
- Andorra
- Bermuda
How they compare
Andorra currently reports 2 against 2 in Bermuda, a difference of 0.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Bermuda ahead.
Andorra ranks 143rd and Bermuda ranks 143rd of 155 countries.
Bermuda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | Bermuda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.33 | 1.33 | 0 | — |
| 2020s | 1.5 | 2 | 0.5 | Bermuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Andorra or Bermuda?
- Andorra, at 2 against 2 in Bermuda as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Andorra and Bermuda?
- 0, with Andorra ahead.
- How many years of comparable data are there for Andorra and Bermuda?
- 5 years are reported by both, from 2017 to 2021.
- How do Andorra and Bermuda rank globally for the number of people with susceptibility test result for rifampicin?
- Andorra ranks 143rd and Bermuda ranks 143rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.